SEC Comment Letter for Orgenesis Inc. (ORGS) (CIK 0001460602) (ORGS) — Jun 11, 2024
Orgenesis Inc. (ORGS) (CIK 0001460602)
Date: June 11, 2024 · CIK: 0001460602 · Accession: 0000000000-24-006690
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279993
Letter
United States securities and exchange commission logo June 11, 2024 Vered Caplan Chief Executive Officer Orgenesis Inc. 20271 Goldenrod Lane Germantown, MD 20876 Re:Orgenesis Inc. Registration Statement on Form S-3 Filed June 6, 2024 File No. 333-279993 Dear Vered Caplan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey Cohan
Show Raw Text
United States securities and exchange commission logo
June 11, 2024
Vered Caplan
Chief Executive Officer
Orgenesis Inc.
20271 Goldenrod Lane
Germantown, MD 20876
Re:Orgenesis Inc.
Registration Statement on Form S-3
Filed June 6, 2024
File No. 333-279993
Dear Vered Caplan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jeffrey Cohan